Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06864390

Genicular Nerve Phenol Neurolysis Versus Radiofrequency Ablation for Pain Relief in Grade 4 Knee Osteoarthritis

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
114 (estimated)
Sponsor
Ain Shams University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to compare the efficiency and efficacy of genicular nerves blockade by chemical phenol neurolysis versus radiofrequency ablation in managing pain in patients suffering from grade IV KOA in term of NRS pain score. The participants will be evaluated by numeric rating scale and oxford knee score for assessment of pain relief up to 16 weeks.

Conditions

Interventions

TypeNameDescription
PROCEDUREgenicular nerve neurolysisThe superior medial genicular nerve (SMGN), superior lateral genicular nerve (SLGN), and inferior medial genicular nerve (IMGN) will be blocked either by phenol neurolysis or radiofrequency ablation

Timeline

Start date
2025-04-01
Primary completion
2025-11-01
Completion
2025-11-01
First posted
2025-03-07
Last updated
2025-03-07

Source: ClinicalTrials.gov record NCT06864390. Inclusion in this directory is not an endorsement.

Genicular Nerve Phenol Neurolysis Versus Radiofrequency Ablation for Pain Relief in Grade 4 Knee Osteoarthritis (NCT06864390) · Clinical Trials Directory